Effects of personalized therapy-effect predictions on statin treatment decisions by patients and physicians: a three-armed, blinded, randomized controlled trial

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Ms Nicole Elise Maria Jaspers

University Medical Center Utrecht, Utrecht (Netherlands (The))

14 More presentations in this session

Presentation thumbnail

Patient characteristics and treatment patterns in patients on lipid-lowering therapies following an acute coronary syndrome in France

Professor E. Bruckert (Paris, FR)

Abstract Slides

Presentation thumbnail

What is the most important residual risk after achievement of appropriate low-density lipoprotein cholesterol lowering therapy in secondary prevention of Japanese patients?

Doctor A. Endo (Izumo, JP)

Presentation thumbnail

Association of adherence and treatment intensity of lipid-lowering therapy with cardiovascular outcomes and all-cause mortality in very high-risk patients in Germany

Professor I. Ahrens (Cologne, DE)

Presentation thumbnail

Relative fat mass (RFM) is a better predictor of dyslipidemia and metabolic syndrome than body mass index (BMI).

Doctor O. Kobo (Hadera, IL)

Abstract Slides

Presentation thumbnail

Low levels of low density lipoprotein cholesterol and cardiovascular, cancer and all-cause mortality outcomes

Professor K. Sung (Seoul, KR)

Access the full session

Session thumbnail

Poster Session 1 - Lipids

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Making personalised prevention everyone's business

Congress Presentation

Should we intervene early in patients with asymptomatic aortic stenosis?

Congress Presentation

Cardiovascular prevention in older adults

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources